Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2019.04.29
关于深圳市多普乐实业生长有限公司2018年度业绩允许完成情形说明的专项审核报告
2019.04.29
关于全资孙公司向银行申请授信额度的通告
2019.04.29
关于举行2018年年度报告网上说明会的通告
2019.04.29
2018年度监事会事情报告
2019.04.29
内部控制审计报告
2019.04.29
关于公司会计政策变换的通告
2019.04.29
中天堂富证券有限公司关于公司2018年度召募资金存放与使用情形的专项核查意见
2019.04.29
2018年度财务决算报告
2019.04.29
关于公司召募资金年度存放与现实使用情形的鉴证报告
2019.04.29
关于深圳市多普乐实业生长有限公司2018年度业绩允许完成情形的说明
第一页
上一页
44
45
46
47
48
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】